Clinical Trials Browser

Phase 1 × Mesenchymal Stem Cell Transplantation × 90 days × Clear all

NCT02962661 2026-01-07

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

Phase 1 Recruiting

Other hematologic neoplasm

Heart Failure, Cardiomyopathies, Hematologic Neoplasms